Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Astrazeneca (AZN) Share News

12345678910

AstraZeneca breast cancer therapy wins recommendation for EU approval

28th Feb 2025 15:26

(Alliance News) - AstraZeneca PLC on Friday said its breast cancer therapy, Enhertu, which is being developed jointly with Tokyo-based pharmaceutical company Daiichi Sankyo Co Ltd, has been recommended for approval in the EU. Read More

AstraZeneca's camizestrant has benefit in advanced breast cancer trial

26th Feb 2025 09:27

(Alliance News) - AstraZeneca PLC on Wednesday said its drug camizestrant significantly delayed disease progression in a phase III trial for advanced hormone receptor-positive breast cancer, supporting its potential as a new treatment option. Read More

LONDON MARKET CLOSE: Lloyds and Centrica star on down day for FTSE 100

20th Feb 2025 16:57

(Alliance News) - The FTSE 100 ended lower on Thursday, not helped by a weak start on Wall Street, hurt by a handful of its heavyweight names going ex-dividend. Read More

LONDON MARKET MIDDAY: Ex-dividend stocks stifle FTSE 100

20th Feb 2025 12:09

(Alliance News) - European blue-chips traded mixed on Thursday afternoon, with measures in Paris and Frankfurt rising, but that same positivity eluding the FTSE 100 in London. Read More

LONDON MARKET OPEN: FTSE 100 underperforms but Centrica jumps

20th Feb 2025 09:04

(Alliance News) - European stocks opened mixed on Thursday, with the FTSE 100 underperforming, as Russia-Ukraine uncertainty, tariff worries and the possibility of higher for longer interest rates cloud over stocks. Read More

LONDON MARKET MIDDAY: Strong pound pegs FTSE 100 but mid-caps prosper

14th Feb 2025 11:58

(Alliance News) - The FTSE 100 traded lower around midday, as gains in sterling kept a lid on some dollar earners offsetting strong gains in miners. Read More

UK dividends calendar - next 7 days

13th Feb 2025 14:02

Read More

LONDON BROKER RATINGS: UBS raises AstraZeneca to 'buy'

13th Feb 2025 09:35

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday: Read More

LONDON BRIEFING: Barclays and Unilever announce buybacks

13th Feb 2025 07:54

(Alliance News) - London's FTSE 100 is called to open slightly lower on Thursday, while the pound climbed after better-than-expected UK data. Read More

LONDON BROKER RATINGS: Morgan Stanley likes Astra; HSBC cuts Spectris

12th Feb 2025 09:58

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday: Read More

LONDON BRIEFING: Barratt Redrow eyes profit at top end of market view

12th Feb 2025 07:49

(Alliance News) - London's FTSE 100 is called to open flat on Wednesday, failing to replicate some more confident trade seen in Asia, with a US inflation reading ahead. Read More

LONDON BROKER RATINGS: Peel Hunt raises Fevertree to 'hold'

11th Feb 2025 09:52

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday: Read More

LONDON BROKER RATINGS: Deutsche Bank raises Victrex, cuts Fevertree

10th Feb 2025 09:59

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday: Read More

LONDON MARKET CLOSE: BoE rate cut and AstraZeneca drive stocks higher

6th Feb 2025 16:51

(Alliance News) - The FTSE 100 closed sharply higher on Thursday, just shy of a new all-time peak, after the Bank of England lowered interest rates with a more 'dovish' vote split than forecast. Read More

LONDON MARKET MIDDAY: FTSE 100 jumps and pound sinks as BoE cuts

6th Feb 2025 12:15

(Alliance News) - Stock prices in Europe pushed higher on Thursday, as a lack of tariff tit-for-tat news supported equities, while the Bank of England announced a rate cut which turbocharged the FTSE 100. Read More

Cancer drugs help drive fourth-quarter sales beat at AstraZeneca

6th Feb 2025 08:42

(Alliance News) - AstraZeneca PLC on Thursday ended a strong year with better-than-expected fourth quarter earnings and said its pipeline would support further growth in 2025. Read More

LONDON MARKET OPEN: Risk appetite returns ahead of BoE decision

6th Feb 2025 08:34

(Alliance News) - Stock prices in London opened higher on Thursday, with the absence of new tariff salvos boosting risk appetite, while the pound faded from the USD1.25 mark before a Bank of England decision. Read More

LONDON BRIEFING: AstraZeneca profit up; BBGI backs GBP1.1 billion bid

6th Feb 2025 07:49

(Alliance News) - London's FTSE 100 is called to open higher on Thursday, with risk appetite returning after a week which has so far been marred by trade war worries. Read More

IN BRIEF: Indivior completes USD100 million share buyback

4th Feb 2025 10:41

Indivior PLC - Richmond, Virginia-based maker of medicines to treat substance use disorders - Completes share buyback programme begun in July. Indivior buys back 9.4 million shares at average GBP8.25, worth GBP77.7 million, about USD100.0 million, in total. The buyback was run by Morgan Stanley & Co International PLC. Last week, Indivior promoted David Wheadon to chair, starting immediately. Wheadon joined the Indivior board in June last year. Wheadon is a medical doctor who worked for GlaxoSmithKline, now GSK PLC, and Eli Lilly & Co. Until 2019, he was senior vice president of global regulatory affairs, patient safety & quality assurance at AstraZeneca PLC. Read More

AstraZeneca's Imfinzi endorsed for EU approval for lung cancer care

3rd Feb 2025 08:34

(Alliance News) - AstraZeneca PLC on Monday said Imfinzi has been recommended for approval in the EU as monotherapy for limited-stage small cell lung cancer. Read More

12345678910
FTSE 100 Latest
Value8,809.74
Change53.53